Othera is a pharmaceutical company developing novel therapeutics for age-related diseases of the eye. Othera's lead compound, OT-551 is an eye drop in a Phase II clinical trial for the dry form of macular degeneration (AMD), and recently announced positive interim data from that trial, with full tri... Read more
This company has no org chart yet
This company has no teams yet
This company has no offices yet